We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Caution Urged in Extrapolating Data On the Teratogenic Effects of Drugs

JAMA. 1965;191(3):38-40. doi:10.1001/jama.1965.03080030116039.
Text Size: A A A
Published online


A New York physician urged caution in extrapolating data on the teratogenic effects of drugs obtained in laboratory animals to humans at the 131st annual meeting of the American Association for the Advancement of Science in Montreal.

John J. Burns, MD, director of research at Burroughs Wellcome and Company, Tuckahoe, NY, discussed several ways in which differences in species, long-term administration in high doses, and other factors regarding metabolization and distribution of a drug may affect the evaluation of the drug's teratogenicity.

"Species differing in drug metabolism make it difficult to project pharmacological and toxicological data obtained in experimental animals to man," he said. He attributed this difficulty to differences in the actual rate of metabolism as well as to qualitative differences in metabolic pathways. Studies with an anti-inflammatory agent, phenylbutazone, show that a drug is metabolized in man at a very slow rate with a half-life which averages three


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.